Despite mixed phase 3 showing, Apellis hopes to push eye disorder drug past FDA’s finish line nhigginsdunn Thu, 09/09/2021 – 15:34 More: Despite mixed phase 3 showing, Apellis hopes to push eye disorder drug past FDA's finish line Source: fierce
read moreBiogen CEO blames Aduhelm’s rocky launch on ‘too much confusion, misinformation and controversy’ esagonowsky Thu, 09/09/2021 – 14:20 More: Biogen CEO blames Aduhelm’s rocky launch on 'too much confusion, misinformation and controversy' Source: fierce
read moreTossing same-old pharma marketing, agency veteran turns to Clubhouse and digital health democracy for inspiration bbulik Thu, 09/09/2021 – 13:06 More: Tossing same-old pharma marketing, agency veteran turns to Clubhouse and digital health democracy for inspiration Source: fierce
read moreAcorda slashes jobs again as generics hamper sales of MS drug klahucik Thu, 09/09/2021 – 11:47 More: Acorda slashes jobs again as generics hamper sales of MS drug Source: fierce
read morePerrigo dishes out $2.1B for HRA Pharma, a big step on its quest to become self-care heavyweight nhigginsdunn Thu, 09/09/2021 – 11:37 More: Perrigo dishes out .1B for HRA Pharma, a big step on its quest to become self-care heavyweight
read moreThe trial will aim to enrol 640 healthy adults, aged 50- to 70-years-old More: Novavax begins COVID-19, flu combination vaccine trial Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals